@cerespir.com
Cerespir is an operator of a biotechnology company intended to treat neurodegenerative disorders.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
CereSpir is a pioneering brand at the forefront of developing advanced therapeutic agents to combat neurotoxicity in conditions such as Parkinson's disease. Their lead compound, itanapraced (CSP-1103), is currently under development and will soon enter Phase 2 clinical trials. Itanapraced stands out due to its small molecule structure, which allows for easy oral administration and excellent bioavailability.
It also boasts a long plasma half-life and has the ability to penetrate the brain effectively. What sets it apart is its remarkable clinical trial results. In a Phase 2 study, patients with mild cognitive impairment experienced significant reductions in neuroinflammatory mediators, soluble CD40 ligand, and TNF-Ξ±, as well as total tau, a marker of neurodegeneration.
Moreover, patients displayed stable cognitive function throughout the lengthy trial period, confirming the compound's efficacy. CereSpir is proud to possess the most advanced compound targeting LRRK-mediated neurotoxicity and has gathered substantial clinical trial experience with over 200 human subjects. With their focus on developing innovative solutions, CereSpir aims to revolutionize the treatment landscape for neurodegenerative diseases
Company Size
11-50
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories